68 related articles for article (PubMed ID: 37946254)
1. Real-World Impact of an In-House Dihydropyrimidine Dehydrogenase (
Nguyen DG; Morris SA; Hamilton A; Kwange SO; Steuerwald N; Symanowski J; Moore DC; Hanson S; Mroz K; Lopes KE; Larck C; Musselwhite L; Kadakia KC; Koya B; Chai S; Osei-Boateng K; Kalapurakal S; Swift K; Hwang J; Patel JN
JCO Precis Oncol; 2024 Jun; 8():e2300623. PubMed ID: 38935897
[TBL] [Abstract][Full Text] [Related]
2. DPYD genotyping and 5-fluoropyrimidine toxicity: An overview of systematic reviews protocol.
Torres SO; Pérez OM; Mauriz RR; Casamartina EF; Martínez SF; Estela AC
Farm Hosp; 2024; 48(2):79-82. PubMed ID: 37758638
[TBL] [Abstract][Full Text] [Related]
3. DPYD genotyping and 5-fluoropyrimidine toxicity: An overview of systematic reviews protocol.
Otero Torres S; Montero Pérez O; Rodríguez Mauriz R; Fort Casamartina E; Fontanals Martínez S; Clopés Estela A
Farm Hosp; 2024; 48(2):T79-T82. PubMed ID: 38072762
[TBL] [Abstract][Full Text] [Related]
4. Consortium analysis of gene and gene-folate interactions in purine and pyrimidine metabolism pathways with ovarian carcinoma risk.
Kelemen LE; Terry KL; Goodman MT; Webb PM; Bandera EV; McGuire V; Rossing MA; Wang Q; Dicks E; Tyrer JP; Song H; Kupryjanczyk J; Dansonka-Mieszkowska A; Plisiecka-Halasa J; Timorek A; Menon U; Gentry-Maharaj A; Gayther SA; Ramus SJ; Narod SA; Risch HA; McLaughlin JR; Siddiqui N; Glasspool R; Paul J; Carty K; Gronwald J; Lubiński J; Jakubowska A; Cybulski C; Kiemeney LA; Massuger LF; van Altena AM; Aben KK; Olson SH; Orlow I; Cramer DW; Levine DA; Bisogna M; Giles GG; Southey MC; Bruinsma F; Kjaer SK; Høgdall E; Jensen A; Høgdall CK; Lundvall L; Engelholm SA; Heitz F; du Bois A; Harter P; Schwaab I; Butzow R; Nevanlinna H; Pelttari LM; Leminen A; Thompson PJ; Lurie G; Wilkens LR; Lambrechts D; Van Nieuwenhuysen E; Lambrechts S; Vergote I; Beesley J; ; Fasching PA; Beckmann MW; Hein A; Ekici AB; Doherty JA; Wu AH; Pearce CL; Pike MC; Stram D; Chang-Claude J; Rudolph A; Dörk T; Dürst M; Hillemanns P; Runnebaum IB; Bogdanova N; Antonenkova N; Odunsi K; Edwards RP; Kelley JL; Modugno F; Ness RB; Karlan BY; Walsh C; Lester J; Orsulic S; Fridley BL; Vierkant RA; Cunningham JM; Wu X; Lu K; Liang D; Hildebrandt MA; Weber RP; Iversen ES; Tworoger SS; Poole EM; Salvesen HB; Krakstad C; Bjorge L; Tangen IL; Pejovic T; Bean Y; Kellar M; Wentzensen N; Brinton LA; Lissowska J; Garcia-Closas M; Campbell IG; Eccles D; Whittemore AS; Sieh W; Rothstein JH; Anton-Culver H; Ziogas A; Phelan CM; Moysich KB; Goode EL; Schildkraut JM; Berchuck A; Pharoah PD; Sellers TA; Brooks-Wilson A; Cook LS; Le ND
Mol Nutr Food Res; 2014 Oct; 58(10):2023-35. PubMed ID: 25066213
[TBL] [Abstract][Full Text] [Related]
5. DPYD genetic polymorphisms in non-European patients with severe fluoropyrimidine-related toxicity: a systematic review.
Chan TH; Zhang JE; Pirmohamed M
Br J Cancer; 2024 Jun; ():. PubMed ID: 38886557
[TBL] [Abstract][Full Text] [Related]
6. Beyond Rare-Variant Association Testing: Pinpointing Rare Causal Variants in Case-Control Sequencing Study.
Lin WY
Sci Rep; 2016 Feb; 6():21824. PubMed ID: 26903168
[TBL] [Abstract][Full Text] [Related]
7. Mutational landscape of risk variants in comorbid depression and obesity: a next-generation sequencing approach.
Pérez-Gutiérrez AM; Carmona R; Loucera C; Cervilla JA; Gutiérrez B; Molina E; Lopez-Lopez D; Pérez-Florido J; Zarza-Rebollo JA; López-Isac E; Dopazo J; Martínez-González LJ; Rivera M
Mol Psychiatry; 2024 May; ():. PubMed ID: 38806690
[TBL] [Abstract][Full Text] [Related]
8. Pharmacogenetic landscape of pain management variants among Mediterranean populations.
Jmel H; Boukhalfa W; Gouiza I; Seghaier RO; Dallali H; Kefi R
Front Pharmacol; 2024; 15():1380613. PubMed ID: 38813106
[TBL] [Abstract][Full Text] [Related]
9. Undetected toxicity risk in pharmacogenetic testing for dihydropyrimidine dehydrogenase.
Falvella FS; Caporale M; Cheli S; Martinetti A; Berenato R; Maggi C; Niger M; Ricchini F; Bossi I; Di Bartolomeo M; Sottotetti E; Bernardi FF; de Braud F; Clementi E; Pietrantonio F
Int J Mol Sci; 2015 Apr; 16(4):8884-95. PubMed ID: 25906475
[TBL] [Abstract][Full Text] [Related]
10. The burden of rare variants in DPYS gene is a novel predictor of the risk of developing severe fluoropyrimidine-related toxicity.
De Mattia E; Polesel J; Silvestri M; Roncato R; Scarabel L; Calza S; Spina M; Puglisi F; Toffoli G; Cecchin E
Hum Genomics; 2023 Nov; 17(1):99. PubMed ID: 37946254
[TBL] [Abstract][Full Text] [Related]
11. Rare genetic variant burden in DPYD predicts severe fluoropyrimidine-related toxicity risk.
De Mattia E; Silvestri M; Polesel J; Ecca F; Mezzalira S; Scarabel L; Zhou Y; Roncato R; Lauschke VM; Calza S; Spina M; Puglisi F; Toffoli G; Cecchin E
Biomed Pharmacother; 2022 Oct; 154():113644. PubMed ID: 36063648
[TBL] [Abstract][Full Text] [Related]
12. Clinical relevance of DPYD variants c.1679T>G, c.1236G>A/HapB3, and c.1601G>A as predictors of severe fluoropyrimidine-associated toxicity: a systematic review and meta-analysis of individual patient data.
Meulendijks D; Henricks LM; Sonke GS; Deenen MJ; Froehlich TK; Amstutz U; Largiadèr CR; Jennings BA; Marinaki AM; Sanderson JD; Kleibl Z; Kleiblova P; Schwab M; Zanger UM; Palles C; Tomlinson I; Gross E; van Kuilenburg AB; Punt CJ; Koopman M; Beijnen JH; Cats A; Schellens JH
Lancet Oncol; 2015 Dec; 16(16):1639-50. PubMed ID: 26603945
[TBL] [Abstract][Full Text] [Related]
13. Common dihydropyrimidinase ( DPYS ) genetic variations do not predict fluoropyrimidine-related chemotherapy toxicity in a Canadian cohort.
Medwid SJ; Mailloux JL; Wigle TJ; Kim RB
Pharmacogenet Genomics; 2024 Apr; 34(3):83-87. PubMed ID: 38215018
[TBL] [Abstract][Full Text] [Related]
14. Pretreatment serum uracil concentration as a predictor of severe and fatal fluoropyrimidine-associated toxicity.
Meulendijks D; Henricks LM; Jacobs BAW; Aliev A; Deenen MJ; de Vries N; Rosing H; van Werkhoven E; de Boer A; Beijnen JH; Mandigers CMPW; Soesan M; Cats A; Schellens JHM
Br J Cancer; 2017 May; 116(11):1415-1424. PubMed ID: 28427087
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
